ÇAVDAR, Z. Et Al. 2019. Paricalcitol pretreatment attenuates renal ischemia/reperfusion injury by inhibiting p38 MAPK and activating PI3K/Akt signaling pathways. TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4 , 452-461.

ÇAVDAR, Z., URAL ÖZKAN, C., Kocak, A., ARSLAN, Ş., Ersan, S., ÖZBAL, S., ... Tatli, M.(2019). Paricalcitol pretreatment attenuates renal ischemia/reperfusion injury by inhibiting p38 MAPK and activating PI3K/Akt signaling pathways. TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4, 452-461.

ÇAVDAR, ZAHİDE Et Al. "Paricalcitol pretreatment attenuates renal ischemia/reperfusion injury by inhibiting p38 MAPK and activating PI3K/Akt signaling pathways," TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4, 452-461, 2019

ÇAVDAR, ZAHİDE Et Al. "Paricalcitol pretreatment attenuates renal ischemia/reperfusion injury by inhibiting p38 MAPK and activating PI3K/Akt signaling pathways." TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4, pp.452-461, 2019

ÇAVDAR, Z. Et Al. (2019) . "Paricalcitol pretreatment attenuates renal ischemia/reperfusion injury by inhibiting p38 MAPK and activating PI3K/Akt signaling pathways." TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , vol.44, no.4, pp.452-461.

@article{article, author={ZAHİDE ÇAVDAR Et Al. }, title={Paricalcitol pretreatment attenuates renal ischemia/reperfusion injury by inhibiting p38 MAPK and activating PI3K/Akt signaling pathways}, journal={TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI}, year=2019, pages={452-461} }